Well, it was fun while it lasted. Glove and condom maker Ansell's share price has risen 14% since we initially upgraded it in Ansell: bad news, good news from 4 Feb 16 (Buy – $15.49). Thankfully our Growth and Equity Income portfolios managed to start small holdings in the stock at $15.05. But with a forward price-earnings ratio of around 13, we're downgrading Ansell to HOLD.
Disclosure: The author owns shares in Ansell.